-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
August 13, 2020 // -- Scientists from Vanderburg University and others have revealed the culprits for acute gastroenteritis in a recent study published in the international journal Clinical Infectious Diseases entitled "Features of GII.4 Norovirus other Genotypes in Sporadic Pediatrics in County Davidson, Tennessee, USA."
Photo Source: CC0 Public Domain Noru virus infection is the main cause of acute gastroenteritis, noruvirus has at least 49 different virus genotypes, of which GII.4 genotype is the main cause of the outbreak of noel virus, currently researchers do not know about clinically related to acute gastroenteritis related to noru virus genotype.
researcher Dr Zaid Haddadin said: 'Over the past three years, we have compared the clinical characteristics and distribution of noel virus genotypes in different children's bodies by collecting samples from children treated with acute gastroenteritis in three clinical settings (outpatients, emergency patients and inpatients).
Of the 2,885 children, the detection rate of noel virus in feces was 22%, nearly 90% of the positive children were GII genotypes, and the proportion of GII.4 genotypes in GII genotype-positive samples was 51%.
researchers point out that children infected with the GII.4 genotype noruvirus tend to be smaller and have more severe symptoms of infection than children with non-GII.4 genotype noru virus infection;
original source: Zaid Haddadin et al. Features of GII.4 Norovirus versus other Genotypes in Sporadic Pediatrics In Davidson County, Tennessee, USA, Clinical Analytics Diseases (2020). DOI:10.1093/cid/ciaa1001.